SCHEMBL22966520

SCHEMBL22966520

CC(C(=O)NS(C)(=O)=O)N1CCc2nc(C(C)(C)C)sc2C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGA O60502 1/20 0.34
GRM5 P41594 2/20 0.33
GCK P35557 2/20 0.33
PIK3CA P42336 5/20 0.32
PIK3CB P42338 5/20 0.32
PIK3CG P48736 5/20 0.32
PIK3CD O00329 4/20 0.32
PI4KB Q9UBF8 2/20 0.32
PIK3C3 Q8NEB9 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
GRAMD1A Q96CP6 1/20 0.32
ALDH1A1 P00352 2/20 0.31
POLB P06746 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
F10 P00742 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22966673 0.82 OGA (0.36) OGAGRM5NPC1RAB9AGRAMD1A
SCHEMBL22966531 0.78 NPC1 (0.35) GRM5PIK3CAPIK3CBPIK3CGPIK3CD
SCHEMBL2698658 0.76 KDM4E (0.38) OGAGRM5GCKALDH1A1KDM4E
SCHEMBL22966544 0.76 PIK3CA (0.34) GRM5PIK3CAPIK3CBPIK3CGPIK3CD
SCHEMBL22966640 0.74 PDCD1 (0.42) F10PDCD1CD274HDAC3HDAC1
SCHEMBL22966582 0.73 RAD52 (0.34) OGAGRM5NPC1RAB9AALDH1A1
SCHEMBL2699242 0.72 GRM5 (0.53) OGAGRM5PIK3CAPIK3CBPIK3CG
SCHEMBL22966676 0.69 ALDH1A1 (0.45) GRM5NPC1RAB9AALDH1A1POLB
SCHEMBL12340949 0.69 GRM5 (0.39) GRM5GCKNPC1RAB9AGRAMD1A
SCHEMBL20368922 0.69 GRM5 (0.42) GRM5PIK3CAPIK3CBPIK3CGPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040118-A1 IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF BETTA PHARMACEUTICALS CO., LTD (CN) 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040118-A1 IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF IL2, IL5, TSLP OGA 3447/4885GRM5 1757/4885GCK 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.